ABIOMED, Inc. (ABMD): Price and Financial Metrics

ABIOMED, Inc. (ABMD): $350.61

1.65 (+0.47%)

POWR Rating

Component Grades














  • ABMD scores best on the Quality dimension, with a Quality rank ahead of 89.69% of US stocks.
  • The strongest trend for ABMD is in Quality, which has been heading down over the past 48 weeks.
  • ABMD ranks lowest in Sentiment; there it ranks in the 13th percentile.

ABMD Stock Summary

  • With a one year PEG ratio of 7,266.66, Abiomed Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.49% of US stocks.
  • ABMD's current price/earnings ratio is 102.56, which is higher than 92.32% of US stocks with positive earnings.
  • The ratio of debt to operating expenses for Abiomed Inc is higher than it is for about merely 0.49% of US stocks.
  • Stocks that are quantitatively similar to ABMD, based on their financial statements, market capitalization, and price volatility, are STMP, JAZZ, MASI, ANIK, and TTWO.
  • ABMD's SEC filings can be seen here. And to visit Abiomed Inc's official web site, go to www.abiomed.com.

ABMD Valuation Summary

  • In comparison to the median Healthcare stock, ABMD's price/sales ratio is 365.79% higher, now standing at 17.7.
  • Over the past 243 months, ABMD's price/earnings ratio has gone up 128.3.
  • ABMD's price/sales ratio has moved up 4.3 over the prior 243 months.

Below are key valuation metrics over time for ABMD.

Stock Date P/S P/B P/E EV/EBIT
ABMD 2021-08-31 17.7 12.6 107.0 75.0
ABMD 2021-08-30 17.5 12.5 106.1 74.4
ABMD 2021-08-27 17.4 12.4 105.4 73.9
ABMD 2021-08-26 17.4 12.4 105.4 73.9
ABMD 2021-08-25 17.4 12.4 105.2 73.8
ABMD 2021-08-24 17.4 12.4 105.1 73.7

ABMD Growth Metrics

  • Its year over year price growth rate is now at 42.62%.
  • The 2 year net cashflow from operations growth rate now stands at 63.56%.
  • Its 2 year net income to common stockholders growth rate is now at 80.98%.
Over the past 33 months, ABMD's revenue has gone up $245,011,000.

The table below shows ABMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 935.257 298.178 154.412
2021-03-31 847.522 274.578 225.525
2020-12-31 812.935 274.696 200.467
2020-09-30 802.856 285.001 207.816
2020-06-30 798.066 282.051 158.674
2020-03-31 840.883 314.92 203.009

ABMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABMD has a Quality Grade of B, ranking ahead of 89.71% of graded US stocks.
  • ABMD's asset turnover comes in at 0.655 -- ranking 58th of 181 Medical Equipment stocks.
  • INGN, ATRC, and BSX are the stocks whose asset turnover ratios are most correlated with ABMD.

The table below shows ABMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.655 0.817 0.217
2021-03-31 0.616 0.809 0.303
2020-12-31 0.623 0.809 0.278
2020-09-30 0.643 0.808 0.303
2020-06-30 0.667 0.812 0.248
2020-03-31 0.721 0.820 0.293

ABMD Price Target

For more insight on analysts targets of ABMD, see our ABMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $387.33 Average Broker Recommendation 1.65 (Moderate Buy)

ABMD Stock Price Chart Interactive Chart >

Price chart for ABMD

ABMD Price/Volume Stats

Current price $350.61 52-week high $387.40
Prev. close $348.96 52-week low $242.73
Day low $350.32 Volume 129,428
Day high $353.79 Avg. volume 268,243
50-day MA $342.23 Dividend yield N/A
200-day MA $319.00 Market Cap 15.91B

ABIOMED, Inc. (ABMD) Company Bio

ABIOMED Inc. develops, and sells medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company was founded in 1981 and is based in Danvers, Massachusetts.

ABMD Latest News Stream

Event/Time News Detail
Loading, please wait...

ABMD Latest Social Stream

Loading social stream, please wait...

View Full ABMD Social Stream

Latest ABMD News From Around the Web

Below are the latest news stories about Abiomed Inc that investors may wish to consider to help them evaluate ABMD as an investment opportunity.

Here's Why You Should Retain Abiomed (ABMD) Stock For Now

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

Yahoo | September 20, 2021

New Study from StrategyR Highlights a $80.1 Million Global Market for Tipper Trucks by 2026

SAN FRANCISCO , Sept. 15, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Tipper Trucks - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE Edition: 9; Released: April 2021 Executive Pool: 422 Companies: 43 - Players covered include Abbott Vascular; Abiomed, Inc.; AtriCure, Inc.; BEML Ltd.; Biosensors International Group Ltd.; Biotronik SE & Co. KG; BioVentrix, Inc.; Caterpillar, Inc.; Hitachi Construction Machinery Co., Ltd.; Komatsu Ltd.; OJSC Belaz and Others. Coverage: All major geographies and key segments Segments: Segment (Tipper Truc...

Benzinga | September 15, 2021

2 Hot Stocks to Buy and Hold Until You Retire

Holding stocks for years and years is one of the best ways to get massive returns. But when you're planning to buy for a long hold, you'll need to pick companies that are capable of persistently thriving in an ever-changing world.

Yahoo | September 15, 2021

Return Trends At Abiomed (NASDAQ:ABMD) Aren't Appealing

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...

Yahoo | September 13, 2021

Abiomed (ABMD) Up 6% Since Last Earnings Report: Can It Continue?

Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 3, 2021

Read More 'ABMD' Stories Here

ABMD Price Returns

1-mo -1.96%
3-mo 12.54%
6-mo 16.33%
1-year 34.79%
3-year -16.44%
5-year 183.83%
YTD 8.15%
2020 90.05%
2019 -47.52%
2018 73.44%
2017 66.32%
2016 24.81%

Continue Researching ABMD

Here are a few links from around the web to help you further your research on Abiomed Inc's stock as an investment opportunity:

Abiomed Inc (ABMD) Stock Price | Nasdaq
Abiomed Inc (ABMD) Stock Quote, History and News - Yahoo Finance
Abiomed Inc (ABMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9902 seconds.